{"id":"W4200443315","doi":"10.1182/blood-2021-154155","title":"Long-Term Follow-up of the Combination of Low-Intensity Chemotherapy Plus Inotuzumab Ozogamicin with or without Blinatumomab in Patients with Relapsed-Refractory Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Blinatumomab; Medicine; Vincristine; Internal medicine; Rituximab; Chemotherapy; Acute lymphocytic leukemia; Gastroenterology; Chemotherapy regimen; Chills; Cyclophosphamide; Surgery; Oncology; Leukemia; Lymphoblastic Leukemia; Lymphoma","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008203889,0.0003216683,0.0009660945,0.0002267232,0.0004402891,0.0005042751,0.0002570187,0.0005177082,0.0008266975],"category_scores_gemma":[0.0009816787,0.0001693938,0.0007764376,0.0003022853,0.0002385253,0.0004766733,0.0002787683,0.0011248,0.0002594505],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000446582,"about_ca_system_score_gemma":0.0003071735,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006232021,"about_ca_topic_score_gemma":0.0008565636,"domain_scores_codex":[0.9996874,0.00009337965,0.00003383735,0.00007135134,0.00004200329,0.0000720822],"domain_scores_gemma":[0.9992374,0.0001591952,0.0001987291,0.00006671251,0.00007764172,0.0002603395],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1522033,0.006919016,0.6861275,0.0003725523,0.002555558,0.002182303,0.0005651193,0.001620587,0.02418398,0.0001510845,0.001475195,0.1216439],"study_design_scores_gemma":[0.005901246,0.09523936,0.8828636,0.00008325576,0.003453716,0.001701605,0.0002378579,0.00177824,0.003304143,0.0001942254,0.005185752,0.00005695218],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969984,0.001995548,0.0001723541,0.00006556381,0.00002629526,0.00004964503,0.0002010938,0.000007058973,0.0004840317],"genre_scores_gemma":[0.9986002,0.0003516276,0.0000667991,0.0001083908,0.00003398602,0.00004529558,0.0004986081,0.000002031518,0.0002930749],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009660945,"threshold_uncertainty_score":0.004338682,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008599248401804548,"score_gpt":0.2394077947778925,"score_spread":0.2308085463760879,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}